In the current climate there are several major challenges or trends in inve...

Now in its third year, the LSX Investor Perception Survey 2019 tracks the v...

Around two thirds (61%) of life science investor respondents look for manag...

As new technologies look to play an ever-increasing role in addressing heal...

On 25 October 2018 the Court of Justice of the European Union (CJEU) handed...

On 5 February 2019, a panel of leading medtech investors will open the 5th ...

In October 2018, German medical device company Protembis closed an oversubs...

On 5-6 February 2019, international life sciences investors, C-level execut...

Senior executives and investors in the life sciences sector will convene in...

Key learnings: Oxford-based Oxehealth has secured medical device accreditat...

In early 2017, LSX, formerly Biotech and Money, published the inaugural Inv...

Biotech and Money is now LSX – The network for life science executive leade...